BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23302268)

  • 21. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
    Kantelip B; Albuisson E; Bacin F; Bonhomme R
    Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Importance of the length of excised optic nerve in enucleations for uveal melanoma].
    Bobić-Randovanović A; Vlatković Z
    Acta Chir Iugosl; 2006; 53(3):49-52. PubMed ID: 17338200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uveal malignant melanoma in a duck.
    Gilger BC; McLaughlin SA; Smith P
    J Am Vet Med Assoc; 1995 May; 206(10):1580-2. PubMed ID: 7775238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic correlations in eyes enucleated after uveal melanoma resection with positive surgical margins.
    Khalifa Y; Aaberg TM; Aaberg TM; Grossniklaus HE
    Indian J Ophthalmol; 2007; 55(5):380-3. PubMed ID: 17699951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of uveal melanoma: a continuing dilemma. Collaborative Ocular Melanoma Study Group.
    Schachat AP
    Cancer; 1994 Dec; 74(11):3073-5. PubMed ID: 7954270
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ring melanoma].
    Szuścik I; Romanowska-Dixon B; Jakubowska B; Orłowska-Heitzman J
    Klin Oczna; 2008; 110(10-12):375-9. PubMed ID: 19195170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selected prognostic factors of malignant uveal melanoma].
    Svetlosáková Z; Krásnik V; Gergisáková H; Babál P; Kusenda P
    Cesk Slov Oftalmol; 2012 Feb; 68(1):38-42. PubMed ID: 22679696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of occult necrotic melanomas.
    Char DH; Cole TB; Crawford JB
    JAMA Ophthalmol; 2013 Aug; 131(8):1067-9. PubMed ID: 23640284
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rationale for implant insertion after enucleation of eyes with uveal melanoma].
    Stoiukhina AS
    Vestn Oftalmol; 2011; 127(1):29-32. PubMed ID: 21539101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
    Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveal melanoma dormancy: an acceptable clinical endpoint?
    Blanco PL; Lim LA; Miyamoto C; Burnier MN
    Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traumatic enucleation for posterior uveal melanoma.
    Specht CS; McLean IW; Biscoe BW
    Am J Ophthalmol; 1990 Nov; 110(5):518-21. PubMed ID: 2240138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of primary intraocular cancers: retinoblastoma and uveal malignant melanoma.
    Boyd-Monk H; Augsburger JJ
    J Ophthalmic Nurs Technol; 1997; 16(4):183-7. PubMed ID: 9335732
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemical assessment of mitotic count in uveal melanoma.
    Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
    Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
    Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
    Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uveal malignant melanoma in Israel (1970-1989)].
    Shargal Y; Pe'er J
    Harefuah; 1995 Nov; 129(10):369-74, 448. PubMed ID: 8647537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.